Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 1/20 | 0.52 |
| ▸ | NPY4R | P50391 | 15/20 | 0.51 |
| ▸ | NPY1R | P25929 | 9/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.51 |
| ▸ | NPY2R | P49146 | 5/20 | 0.51 |
| ▸ | MME | P08473 | 1/20 | 0.50 |
| ▸ | ACE | P12821 | 1/20 | 0.50 |
| ▸ | CPA1 | P15085 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30938822 | 0.92 | F2 (0.50) | NPY4RNPY1RNPY5RNPY2RMME | |
| SCHEMBL30272473 | 0.91 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29641576 | 0.91 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30477221 | 0.91 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31420009 | 0.89 | GNPAT (0.56) | GNPATNPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30111320 | 0.88 | NPY4R (0.43) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL9614927 | 0.87 | NPY4R (0.40) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL15011349 | 0.87 | NPY4R (0.40) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL27732271 | 0.87 | NPY4R (0.40) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30988902 | 0.87 | NPY4R (0.48) | NPY4RNPY1RNPY5RNPY2RMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4445138-A1 | FRET ENZYMATIC SUBSTRATE AND USES THEREOF IN LUNG CANCER | Urteste S.A. (PL) | 2024-10-16 | — | — | EP | claimed |
| WO-2023106945-A1 | FRET ENZYMATIC SUBSTRATE AND USES THEREOF IN LUNG CANCER. | URTESTE S.A. (PL) | 2023-06-15 | — | — | WO | claimed |
| EP-4445138-A1 | FRET ENZYMATIC SUBSTRATE AND USES THEREOF IN LUNG CANCER | Urteste S.A. (PL) | 2024-10-16 | — | — | EP | disclosed |
| WO-2023106945-A1 | FRET ENZYMATIC SUBSTRATE AND USES THEREOF IN LUNG CANCER. | URTESTE S.A. (PL) | 2023-06-15 | — | — | WO | disclosed |